Show simple item record

dc.contributor.authorPfaender, Stephanie
dc.contributor.authorvon Hahn, Thomas
dc.contributor.authorSteinmann, Joerg
dc.contributor.authorCiesek, Sandra
dc.contributor.authorSteinmann, Eike
dc.date.accessioned2017-03-15T09:04:49Z
dc.date.available2017-03-15T09:04:49Z
dc.date.issued2016-09
dc.identifier.citationPrevention strategies for blood-borne viruses-in the Era of vaccines, direct acting antivirals and antiretroviral therapy. 2016, 26 (5):330-9 Rev. Med. Virol.en
dc.identifier.issn1099-1654
dc.identifier.pmid27185010
dc.identifier.doi10.1002/rmv.1890
dc.identifier.urihttp://hdl.handle.net/10033/620859
dc.description.abstractBlood-borne viruses, such as hepatitis B virus, hepatitis C virus, human immunodeficiency virus, and the facultative blood-borne hepatitis E virus, are considered a major public health problem given that they are accountable for millions of deaths each year. Treatment options, including effective vaccine design, development of antiviral strategies and the implementation of antiretroviral therapy have improved substantially over the last couple of years and contribute to successful treatment and prevention of these infectious diseases. In this review, we summarise the current knowledge and concepts in prevention of transmission of these blood-borne viruses.
dc.language.isoenen
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/*
dc.titlePrevention strategies for blood-borne viruses-in the Era of vaccines, direct acting antivirals and antiretroviral therapy.en
dc.typeArticleen
dc.contributor.departmentTwincore Centre of Experimental and Clinical Infection Research; a joint venture between the Hannover Medical School and the Helmholtz Centre for Infection Research, Hannover 30625, Germany.en
dc.identifier.journalReviews in medical virologyen
refterms.dateFOA2018-06-13T19:45:56Z
html.description.abstractBlood-borne viruses, such as hepatitis B virus, hepatitis C virus, human immunodeficiency virus, and the facultative blood-borne hepatitis E virus, are considered a major public health problem given that they are accountable for millions of deaths each year. Treatment options, including effective vaccine design, development of antiviral strategies and the implementation of antiretroviral therapy have improved substantially over the last couple of years and contribute to successful treatment and prevention of these infectious diseases. In this review, we summarise the current knowledge and concepts in prevention of transmission of these blood-borne viruses.


Files in this item

Thumbnail
Name:
Pfaender et al.pdf
Size:
245.5Kb
Format:
PDF
Description:
Open Access article

This item appears in the following Collection(s)

Show simple item record

http://creativecommons.org/licenses/by-nc-sa/4.0/
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by-nc-sa/4.0/